GlassScriptPhysician profile
John F Irwin
NPI 1518960566
$2,111.28
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $117 · 2021: $341 · 2022: $724 · 2023: $562 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.39 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.08 | 2019-2023 | |
| Astellas Pharma US INC | $334.07 | 2019-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $208.87 | 2020-2023 | |
| Myovant Sciences INC. | $165.86 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $129.27 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $122.52 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $93.57 | 2019-2024 | Advincula Delineator Uterine Manipulator |
| Pfizer INC. | $89.23 | 2022-2024 | |
| Hologic Sales and Service, LLC | $77.19 | 2019-2024 | Acessa Provu System, Novasure, Fluent Fluid Management System |
| Medicem INC. | $69.01 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $61.33 | 2023 | |
| Merck Sharp & Dohme LLC | $50.02 | 2021-2023 | Gardasil 9 |
| Aspira Women'S Health INC | $43.41 | 2022-2023 | Ova1 |
| Lupin INC. | $41.91 | 2019 | |
| Mylan Pharmaceuticals INC. | $34.76 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $29.37 | 2019-2020 | |
| Exact Sciences Corporation | $25.17 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $24.08 | 2023 | Nuvessa |
| Medline Industries LP | $22.35 | 2024 | |
| Organon LLC | $21.05 | 2021 | |
| Allergan, INC. | $19.92 | 2020 | |
| Therapeuticsmd, INC. | $16.51 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.76 | 2019 | |
| Avion Pharmaceuticals | $15.16 | 2021 | |
| Millicent US INC | $15.02 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.81 | 2022 | |
| Amgen INC. | $13.98 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Irwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.